US › Healthcare

Universe Pharmaceuticals Inc (UPC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$4.75-0.21%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$9.0M

Revenue YoY

-34.7%

Net profit

$-1.6M

EPS

$-9.44

EPS estimate

$0.00

Net margin

-17.2%

Key statistics

Market cap

$23.9M

Forward P/E

0.0

P/B

0.40

Book value

$98.78

EPS (TTM)

$-1.47

52-week high

$17.96

52-week low

$2.00

50-day MA

$4.89

200-day MA

$3.82

Beta

1.59

Shareholding

Insiders

88.82%

Institutions

1.31%

Largest institutional holders

Fund	Stake
UBS Group AG	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Universe Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.